Page 6 - Ongoing Research Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com's offering. RET inhibitor therapy market is a novel, unique yet a challenging aspect followed by the oncology researchers for the treatment of different types of cancers. Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Report Highlights: Global RET Inhibitors Market Opportunity: > USD 1.5 Billion Global RET Inhibitors Market Absolute Growth : 3900% (2020-2026) RET inhibitors clinical Trials Insight by Company, Country, Indication & Phase RET Inhibitors In Clinical Trials: > 15 Drugs Commercially Avai...

ResearchAndMarkets.com’s offering. RET inhibitor therapy market is a novel, unique yet a challenging aspect followed by the oncology researchers for the treatment of different types of cancers. Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Report Highlights: Global RET Inhibitors Market Opportunity: > USD 1.5 Billion Global RET Inhibitors Market Absolute Growth : 3900% (2020-2026) RET inhibitors clinical Trials Insight by Company, Country, Indication & Phase RET Inhibitors In Clinical Trials: > 15 Drugs Commercially Available RET Inhibitors: 2 (Retevmo and Gav...

Global KRAS Inhibitors Drug Market Sales Size Opportunity Clinical Development To Surpass USD 1 Billion By 2025 NEW DELHI, Feb. 15, 2021 /PRNewswire/ -- "Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" Report Highlights: KRAS Inhibitors Market Opportunity: > USD 1 Billion by 2025 Initially US To Dominate KRAS Inhibitors Market: >90% Market Share Number of KRAS Inhibitors In Trials: > 20 Drugs Highest Phase of Clinical Development: Phase-III Study Solid Tumors Targeted Drugs Dominating The Clinical Trials Global KRAS Inhibitors Market Trends & Dynamics Global K...

Share this article Share this article ResearchAndMarkets.com's offering. The fast pace of cancer prevalence and mortality rate across the globe has led to an increasing concern as well as recognition that the specific disease requires attention by the researchers. In the past few years, the type of research activities that have been conducted for cancer disease has moved several laboratory findings to the commercial world. In one of the scenarios, development of cancer biological toxins is a form of novel technology facility resulted from the translational research conducted at different res...